Vimarsana
Biggest News Aggregation in the World

Page 5 - Fourth Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fourth Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fourth Dose Today - Breaking & Trending Today

Italy approves fourth dose of covid vaccine for over-60s - Vimarsana News

Italy approves fourth dose of covid vaccine for over-60s

Italy has started to offer a fourth dose of the covid vaccine or 'second booster' to the over-60s, Italian health minister Roberto Speranza said on Monday.

Premier Daniel Andrews argues for 'urgent' approval of fourth COVID-19 vaccine dose as he hints at improved Omicron booster - Vimarsana News

Premier Daniel Andrews argues for 'urgent' approval of fourth COVID-19 vaccine dose as he hints at improved Omicron booster

Victorian Premier Daniel Andrews has stopped short of urging Australia's vaccine advisory panel to introduce a fourth dose for healthcare workers as he flagged a potential new booster shot designed specifically for the Omicron subvariants.

Hanoi to inoculate vulnerable adults with fourth dose of COVID-19 vaccines | Health - Vimarsana News

Hanoi to inoculate vulnerable adults with fourth dose of COVID-19 vaccines | Health

Hanoi is considering injecting the second booster dose, or the fourth dose, of COVID-19 vaccines to vulnerable adults or those who jobs put them at high risk for exposure to COVID-19, starting this month.

Second boosters: what the studies tell us about the fourth Covid-19 jab - Vimarsana News

Second boosters: what the studies tell us about the fourth Covid-19 jab

Many countries are offering fourth doses of the vaccines, but most are for at-risk groups like the elderly.

Source: scmp.com
Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes - Vimarsana News

Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes

1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to their matched control over 30 days of follow-up. 2. Patients receiving the fourth dose of BNT162b2 were shown to have a lower rate of death compared to their matched control over 30 days of follow-up. […]